Handmade quality · Free shipping over $75 · Explore the atelier

Propranolol Catalog No.:M13521-10 Perifosine combining with temozolomide reduces

SKU: 73876402374

4.6
USD100.00 USD142.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 18 - Oct 23

Description

Perifosine combining with temozolomide reduces tumor proliferation (a PDGF-driven gliomagenesis) in vivo

Desmethyl Erlotinib (OSI-420 free base) is an active metabolite of Erlotinib

ClH/c1-13-5-6-15(11-19(13)31(22

Tolfenamic acid has been shown to exhibit anti-cancer activities in several types of cancer

InChi: InChI=1S/C26H14N8O7S/c1-9-17-24-30-14(6-39-24)21-28-12(4-37-21)19-27-11(3-35-19)20-29-13(5-36-20)22-31-15(7-38-22)26-32-16(8-42-26)23-33-18(10(2)40-23)25(34-17)41-9/h3-7

Propranolol Catalog No.:M13521-10 Perifosine combining with temozolomide reducesPropranolol is a nonselective adrenergic receptor (AR) antagonist, has high affinity for the 1AR and 2AR with Ki values of 1. 8 nM and 0. 8 nM, respectively. Propranolol inhibits [3H] DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol is used for the study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy. Product information CAS Number: 525 66

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products